SCLX
Scilex Holding CompanyNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$59.78M
P/E Ratio
—
EPS
$-40.50
Beta
1.71
52W High
$34.27
52W Low
$4.20
50-Day MA
$7.38
200-Day MA
$12.98
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.66
PEG Ratio
—
About Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
Fundamentals
| Revenue (TTM) | $33.86M |
| Gross Profit (TTM) | $20.20M |
| EBITDA | $-270.09M |
| Operating Margin | -373.50% |
| Return on Equity | 0.00% |
| Return on Assets | -92.80% |
| Revenue/Share (TTM) | $3.43 |
| Book Value | $-35.44 |
| Price-to-Book | 28.85 |
| Price-to-Sales (TTM) | 1.76 |
| EV/Revenue | 4.611 |
| EV/EBITDA | -2.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 72.10% |
| Shares Outstanding | $7.03M |
| Float | $5.19M |
| % Insiders | 17.56% |
| % Institutions | 13.11% |
Historical Volatility
HV 10-Day
148.46%
HV 20-Day
133.21%
HV 30-Day
132.07%
HV 60-Day
122.90%
HV Rank
71.8%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 6/13/2026